XML 21 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Detail) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Leases
Sep. 30, 2013
Commitments and Contingencies Disclosure [Line Items]        
Number of Options to extend the lease term     2  
Options to extend the lease term, number of options     5 years  
Remaining aggregate rent payable $ 59,400,000   $ 59,400,000  
Research and development expense 11,772,000 9,420,000 36,196,000 26,111,000
InVentiv [Member]
       
Commitments and Contingencies Disclosure [Line Items]        
Recorded Unconditional Purchase Obligation, Due in Remainder of Fiscal Year 300,000   300,000  
Unrecorded Unconditional Purchase Obligation, Change of Amount as Result of Variable Components 630,000   630,000  
DSM [Member]
       
Commitments and Contingencies Disclosure [Line Items]        
Unrecorded Unconditional Purchase Obligation 519,000   519,000  
Helion Biotech ApS
       
Commitments and Contingencies Disclosure [Line Items]        
Research and development expense     200,000  
Selling, General and Administrative Expenses
       
Commitments and Contingencies Disclosure [Line Items]        
Government Grants Under Review       $ 900,000